AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Auctimet VG 2mg/500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Bioaltus Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Auctimet VG 2mg/500mg/0.2mg Tablet SR

Diabexe Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Diabexe Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management, as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor might recommend blood tests to track blood cell counts and liver function.

Uses of Auctimet VG 2mg/500mg/0.2mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Auctimet VG 2mg/500mg/0.2mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Auctimet VG 2mg/500mg/0.2mg Tablet SR whole; do not chew, crush, or fracture it. Administer on an empty stomach.

Common Side effects of Auctimet VG 2mg/500mg/0.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Auctimet VG 2mg/500mg/0.2mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Auctimet VG 2mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume on an empty stomach.

How Auctimet VG 2mg/500mg/0.2mg Tablet SR works:

The extended-release tablet, Auctimet VG, contains a triple-action formulation of antidiabetic agents at doses of 2mg, 500mg, and 0.2mg.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Auctimet VG 2mg/500mg/0.2mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Auctimet VG 2mg/500mg/0.2mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Auctimet VG 2mg/500mg/0.2mg tablet likely poses a breastfeeding safety risk. Preliminary human evidence indicates potential drug transfer to breast milk, with the possibility of infant harm.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Auctimet VG 2mg/500mg/0.2mg Tablet SR, as its use may be unsafe. Medical advice should be sought. The medication is further contraindicated for individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Auctimet VG 2mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. A reduced initial dose is typically prescribed for those with mild to moderate hepatic dysfunction; the medication is contraindicated in cases of severe liver disease.

What if you forget to take Auctimet VG 2mg/500mg/0.2mg Tablet SR :

Should you forget to take a dose of Auctimet VG 2mg/500mg/0.2mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Auctimet VG 2mg/500mg/0.2mg Tablet SR

LabelValue
Potential for Dependence None.
Treatment Category Diabetes medication

FAQs on Auctimet VG 2mg/500mg/0.2mg Tablet SR

Auctimet VG 2mg/500mg/0.2mg extended-release tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus in adults, enhancing blood glucose control when combined with a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion to reduce blood glucose. Metformin reduces hepatic glucose production and increases insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, decreases post-meal blood sugar levels. This medication is unsuitable for type 1 diabetes treatment.
Patients taking Auctimet VG 2mg/500mg/0.2mg SR tablets may experience side effects such as low blood sugar, nausea, diarrhea, taste changes, gas, abdominal pain, headache, rash, and respiratory infections.
Patients with hypersensitivity to Auctimet VG 2mg/500mg/0.2mg Tablet SR constituents or inactive ingredients should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, and those with inflammatory bowel conditions, colonic ulcers, or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Auctimet VG 2mg/500mg/0.2mg SR tablets is unsafe. This combination risks lowering blood glucose, potentially causing hypoglycemia, and elevates the likelihood of lactic acidosis.
Auctimet VG 2mg/500mg/0.2mg SR tablets may induce hypoglycemia. Low blood sugar symptoms can manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremor. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, animals, and other individuals.
Auctimet VG 2mg/500mg/0.2...
79
MRP 96
17% off